Market Cap 3.06B
Revenue (ttm) 139.74M
Net Income (ttm) -79.99M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -57.24%
Debt to Equity Ratio 0.09
Volume 1,183,100
Avg Vol 2,007,806
Day's Range N/A - N/A
Shares Out 103.29M
Stochastic %K 47%
Beta 2.22
Analysts Strong Sell
Price Target $48.21

Company Profile

Beam Therapeutics Inc., a biotechnology company, engages in the development of precision genetic medicines for patients suffering from serious diseases in the United States. Its programs in hematology and genetic disease portfolio include Ristoglogene autogetemcel, a patient-specific, autologous hematopoietic stem cell (HSC) therapy for the treatment of sickle cell disease; BEAM-302, a liver-targeting lipid nanoparticle (LNP) for the treatment of severe alpha-1 antitrypsin deficiency; BEAM-304,...

Industry: Biotechnology
Sector: Healthcare
Phone: 857 327 8775
Website: beamtx.com
Address:
238 Main Street, Cambridge, United States
notreload_ai
notreload_ai Sep. 8 at 4:41 PM
$BEAM shares fell after updated BEAM-302 data showed durable AAT correction. Incremental results sparked classic biotech profit-taking. https://notreload.xyz/xy/beam-therapeutics-sell-the-news-after-encouraging-trial/
0 · Reply
Merlintrader
Merlintrader Sep. 8 at 4:31 PM
Biotech Radar | September 9 edition $ROIV $BEAM $UPB $BMY: clinical progress, evidence and next steps. News through September 8. Free Biotech Catalyst Calendar on Merlintrader. https://www.merlintrader.com/biotech-radar-september-9-2026/
0 · Reply
blueb22
blueb22 Sep. 8 at 4:19 PM
$BEAM - it is joke and reminds us all of current state of casino market, that beam is down on this data update which was good update. But then some articles are like it will take years to get approval for this (as if they were expecting this 302 approval in days or weeks) and need funds and do not have revenue and is not profitable and all that crap. Anyone who are long term investors in Beam and institutions who owns 100% knows the stage of drug, pivotal phase with 50 patients to enroll and then 12 months follow up and then preparing BLA and then submission and all that and it takes 2 + years. Very tough environment for even good Biotech and with good cash on hand.
0 · Reply
Trackdips
Trackdips Sep. 8 at 3:10 PM
Not a fan of the PHARMA stocks but tracker said it had a bounce score of 99 , so had to bite. Exited with a 4.5% gain on $BEAM
0 · Reply
sogenerous
sogenerous Sep. 8 at 2:19 PM
$BEAM got little in 25s on this drop
0 · Reply
MarketILF
MarketILF Sep. 8 at 2:04 PM
$BEAM What a stroke of luck! In with 4,000 shares at $25.51.
0 · Reply
TraderYo12
TraderYo12 Sep. 8 at 1:47 PM
$BEAM this is classic sell the news
0 · Reply
darioras
darioras Sep. 8 at 1:39 PM
$BEAM Added at $25
0 · Reply
Windytimes
Windytimes Sep. 8 at 1:32 PM
$BEAM too funny
0 · Reply
Noobnr1
Noobnr1 Sep. 8 at 1:31 PM
$BEAM wtffffff 😫😫😫
0 · Reply
Latest News on BEAM
Beam Therapeutics falls -12.4%

2026-09-08T16:05:37.000Z - 55 minutes ago

Beam Therapeutics falls -12.4%


Beam Therapeutics falls -12.7%

2026-09-08T14:06:03.000Z - 2 hours ago

Beam Therapeutics falls -12.7%


Beam Therapeutics Transcript: Status update

Sep 8, 2026, 7:00 AM EDT - 6 hours ago

Beam Therapeutics Transcript: Status update


Beam Therapeutics Press release: Status update

Sep 8, 2026, 7:00 AM EDT - 6 hours ago

Beam Therapeutics Press release: Status update


Beam Therapeutics Slides: Status update

Sep 8, 2026, 7:00 AM EDT - 6 hours ago

Beam Therapeutics Slides: Status update


Beam Therapeutics Slides: Corporate presentation

Sep 4, 2026, 7:00 AM EDT - 4 days ago

Beam Therapeutics Slides: Corporate presentation


Beam Therapeutics reports Q2 EPS ($1.18), consensus ($1.13)

2026-08-04T11:56:36.000Z - 5 weeks ago

Beam Therapeutics reports Q2 EPS ($1.18), consensus ($1.13)


Beam Therapeutics Earnings release: Q2 2026

Aug 4, 2026, 7:00 AM EDT - 5 weeks ago

Beam Therapeutics Earnings release: Q2 2026


Beam Therapeutics Quarterly report: Q2 2026

Aug 4, 2026, 7:00 AM EDT - 5 weeks ago

Beam Therapeutics Quarterly report: Q2 2026


Beam Therapeutics Slides: Conference presentation

Jul 9, 2026, 7:00 AM EDT - 2 months ago

Beam Therapeutics Slides: Conference presentation


The Healthcare M&A Wave

Jun 17, 2026, 12:30 PM EDT - 2 months ago

The Healthcare M&A Wave

ABT ALNY AMGN AMRX ANTX AZN BDX


Beam Therapeutics Transcript: AGM 2026

Jun 3, 2026, 10:30 AM EDT - 3 months ago

Beam Therapeutics Transcript: AGM 2026


Beam Therapeutics presents Phase 1/2 data for BEAM-302

2026-05-18T20:35:07.000Z - 3 months ago

Beam Therapeutics presents Phase 1/2 data for BEAM-302


Beam Therapeutics reports Q1 EPS (91c), consensus ($1.01)

2026-05-07T13:39:55.000Z - 4 months ago

Beam Therapeutics reports Q1 EPS (91c), consensus ($1.01)


Beam Therapeutics Earnings release: Q1 2026

May 7, 2026, 7:00 AM EDT - 4 months ago

Beam Therapeutics Earnings release: Q1 2026


Beam Therapeutics Quarterly report: Q1 2026

May 7, 2026, 7:00 AM EDT - 4 months ago

Beam Therapeutics Quarterly report: Q1 2026


Beam Therapeutics rises 10.7%

2026-04-27T16:07:48.000Z - 4 months ago

Beam Therapeutics rises 10.7%


Beam Therapeutics Proxy statement: Proxy filing

Apr 17, 2026, 8:00 AM EDT - 4 months ago

Beam Therapeutics Proxy statement: Proxy filing


Beam Therapeutics Proxy statement: Proxy filing

Apr 17, 2026, 8:00 AM EDT - 4 months ago

Beam Therapeutics Proxy statement: Proxy filing


Beam Therapeutics Transcript: Study result

Mar 25, 2026, 8:00 AM EDT - 5 months ago

Beam Therapeutics Transcript: Study result


Beam Therapeutics Press release: Study result

Mar 25, 2026, 8:00 AM EDT - 5 months ago

Beam Therapeutics Press release: Study result


Beam Therapeutics Slides: Study result

Mar 25, 2026, 8:00 AM EDT - 5 months ago

Beam Therapeutics Slides: Study result


Beam Therapeutics Earnings Call Transcript: Q4 2025

Feb 24, 2026, 8:00 AM EST - 6 months ago

Beam Therapeutics Earnings Call Transcript: Q4 2025


Beam Therapeutics Annual report: Q4 2025

Feb 24, 2026, 8:00 AM EST - 6 months ago

Beam Therapeutics Annual report: Q4 2025


Beam Therapeutics Earnings release: Q4 2025

Feb 24, 2026, 8:00 AM EST - 6 months ago

Beam Therapeutics Earnings release: Q4 2025


Beam Therapeutics Earnings release: Q3 2025

Nov 4, 2025, 4:00 PM EST - 10 months ago

Beam Therapeutics Earnings release: Q3 2025


Beam Therapeutics Quarterly report: Q3 2025

Nov 4, 2025, 4:00 PM EST - 10 months ago

Beam Therapeutics Quarterly report: Q3 2025


Beam Therapeutics Earnings release: Q2 2025

Aug 5, 2025, 7:00 AM EDT - 1 year ago

Beam Therapeutics Earnings release: Q2 2025


Beam Therapeutics Quarterly report: Q2 2025

Aug 5, 2025, 7:00 AM EDT - 1 year ago

Beam Therapeutics Quarterly report: Q2 2025


Beam Therapeutics Quarterly report: Q1 2025

May 6, 2025, 7:00 AM EDT - 1 year ago

Beam Therapeutics Quarterly report: Q1 2025


Beam Therapeutics Earnings release: Q1 2025

May 6, 2025, 7:00 AM EDT - 1 year ago

Beam Therapeutics Earnings release: Q1 2025


Beam Therapeutics Proxy statement: Proxy Filing

Apr 18, 2025, 8:00 AM EDT - 1 year ago

Beam Therapeutics Proxy statement: Proxy Filing


Beam Therapeutics Proxy statement: Proxy Filing

Apr 18, 2025, 8:00 AM EDT - 1 year ago

Beam Therapeutics Proxy statement: Proxy Filing


Beam Therapeutics Transcript: Study Update

Mar 10, 2025, 8:00 AM EDT - 1 year ago

Beam Therapeutics Transcript: Study Update


Beam Therapeutics Press release: Study Update

Mar 10, 2025, 8:00 AM EDT - 1 year ago

Beam Therapeutics Press release: Study Update


Beam Therapeutics Slides: Study Update

Mar 10, 2025, 8:00 AM EDT - 1 year ago

Beam Therapeutics Slides: Study Update


Beam Therapeutics Announces Pricing of Underwritten Offering

Mar 10, 2025, 6:01 AM EDT - 1 year ago

Beam Therapeutics Announces Pricing of Underwritten Offering


Beam Therapeutics Annual report: Q4 2024

Feb 25, 2025, 7:00 AM EST - 1 year ago

Beam Therapeutics Annual report: Q4 2024


Beam Therapeutics Earnings release: Q4 2024

Feb 25, 2025, 7:00 AM EST - 1 year ago

Beam Therapeutics Earnings release: Q4 2024


Beam Therapeutics Transcript: Status Update

Dec 8, 2024, 11:00 PM EST - 1 year ago

Beam Therapeutics Transcript: Status Update


Beam Therapeutics Press release: Status Update

Dec 8, 2024, 11:00 PM EST - 1 year ago

Beam Therapeutics Press release: Status Update


Beam Therapeutics Slides: Status Update

Dec 8, 2024, 11:00 PM EST - 1 year ago

Beam Therapeutics Slides: Status Update


Beam Therapeutics Earnings Call Transcript: Q3 2024

Nov 5, 2024, 8:30 AM EST - 1 year ago

Beam Therapeutics Earnings Call Transcript: Q3 2024


Beam Therapeutics Quarterly report: Q3 2024

Nov 5, 2024, 8:30 AM EST - 1 year ago

Beam Therapeutics Quarterly report: Q3 2024


Beam Therapeutics Earnings release: Q3 2024

Nov 5, 2024, 8:30 AM EST - 1 year ago

Beam Therapeutics Earnings release: Q3 2024


notreload_ai
notreload_ai Sep. 8 at 4:41 PM
$BEAM shares fell after updated BEAM-302 data showed durable AAT correction. Incremental results sparked classic biotech profit-taking. https://notreload.xyz/xy/beam-therapeutics-sell-the-news-after-encouraging-trial/
0 · Reply
Merlintrader
Merlintrader Sep. 8 at 4:31 PM
Biotech Radar | September 9 edition $ROIV $BEAM $UPB $BMY: clinical progress, evidence and next steps. News through September 8. Free Biotech Catalyst Calendar on Merlintrader. https://www.merlintrader.com/biotech-radar-september-9-2026/
0 · Reply
blueb22
blueb22 Sep. 8 at 4:19 PM
$BEAM - it is joke and reminds us all of current state of casino market, that beam is down on this data update which was good update. But then some articles are like it will take years to get approval for this (as if they were expecting this 302 approval in days or weeks) and need funds and do not have revenue and is not profitable and all that crap. Anyone who are long term investors in Beam and institutions who owns 100% knows the stage of drug, pivotal phase with 50 patients to enroll and then 12 months follow up and then preparing BLA and then submission and all that and it takes 2 + years. Very tough environment for even good Biotech and with good cash on hand.
0 · Reply
Trackdips
Trackdips Sep. 8 at 3:10 PM
Not a fan of the PHARMA stocks but tracker said it had a bounce score of 99 , so had to bite. Exited with a 4.5% gain on $BEAM
0 · Reply
sogenerous
sogenerous Sep. 8 at 2:19 PM
$BEAM got little in 25s on this drop
0 · Reply
MarketILF
MarketILF Sep. 8 at 2:04 PM
$BEAM What a stroke of luck! In with 4,000 shares at $25.51.
0 · Reply
TraderYo12
TraderYo12 Sep. 8 at 1:47 PM
$BEAM this is classic sell the news
0 · Reply
darioras
darioras Sep. 8 at 1:39 PM
$BEAM Added at $25
0 · Reply
Windytimes
Windytimes Sep. 8 at 1:32 PM
$BEAM too funny
0 · Reply
Noobnr1
Noobnr1 Sep. 8 at 1:31 PM
$BEAM wtffffff 😫😫😫
0 · Reply
Windytimes
Windytimes Sep. 8 at 1:24 PM
$BEAM nothing to see here- sell the news event. Great results.
0 · Reply
UnoffensiveName
UnoffensiveName Sep. 8 at 1:15 PM
$BEAM They brought it down for me to start a position. Which I am now in. Thank you
0 · Reply
darioras
darioras Sep. 8 at 12:55 PM
$BEAM From +4 to -6%?
1 · Reply
Noobnr1
Noobnr1 Sep. 8 at 11:59 AM
$BEAM 🙏🚀🙏🚀 Next launches for $NYXH $PHAR and $OMER 🤞🤞
0 · Reply
TraderYo12
TraderYo12 Sep. 8 at 11:40 AM
$BEAM 🔥 BEAM short-interest setup Metric Latest Shares sold short 24.37M % of float short 36.71% % of shares outstanding 23.69% Days to cover 16.08 Previous short interest 23.50M Change +3.73%
0 · Reply
PorkchopSquats
PorkchopSquats Sep. 8 at 10:41 AM
0 · Reply
Merlintrader
Merlintrader Sep. 8 at 9:22 AM
$BEAM — Today, September 8, at 7:00 AM EDT, Beam Therapeutics will host a conference call covering the BEAM-302 ERS update. 🎧 [Join the webcast](https://edge.media-server.com/mmc/p/u25qkv4j)
0 · Reply
blueb22
blueb22 Sep. 8 at 12:39 AM
$BEAM - going to be Nice week for Beam!! tomorrow morning 7:00 EST is Beam-302 ERS late breaking date update (or BO announcement - who knows... it is possibility - and I think Lilly and Pfizer are interested in Beam since long) Then Citi conference tomorrow afternoon, Then one conf on Wednesday and then one conf on Thursday morning. Very Very
0 · Reply
OptionRunners
OptionRunners Sep. 4 at 7:55 PM
$BEAM unusual call buyer into the close ahead of data in coming days
0 · Reply
Merlintrader
Merlintrader Sep. 2 at 5:27 AM
Beam Therapeutics ($BEAM) Stock Hub 2026: A Commercial Chief Hired for a 2027 Launch — What Does BEAM-302 Have to Deliver First? Free Biotech Catalyst Calendar on Merlintrader. https://www.merlintrader.com/beam-therapeutics-stock-hub/
0 · Reply
ATTAB0Y
ATTAB0Y Sep. 1 at 12:37 AM
$PRME $CRSP $BEAM The kids are all right! And the CRISPR future is bright! https://youtu.be/hX93o7mfj84?is=FD8SfdS8uLreKejV
1 · Reply
EMT6
EMT6 Aug. 25 at 8:39 PM
$BEAM started position in here last week for the long run. Adding weekly for as long as it’s under $45. Let’s get it
0 · Reply